FDA Regulated SDC-Based Product Development
PURE's SDC technology also shows promise as a broad-spectrum antimicrobial and anti-fungal for use in human and veterinary healthcare products. PURE has initially chosen to pursue approvals through the U.S. Food and Drug Administration (FDA) by partnering with third-party pharmaceutical development companies. Our partner companies assume responsibility for finding and managing the testing and regulatory process for potential FDA regulated SDC-based products. Current product development projects include dermatology, wound care and medical biofilm control products as well as several products for dental industry. An IND for a hand sanitizer is in process.